Skip to content
COVID-19 Immunity Task Force Logo COVID-19 Immunity Task Force Logo
  • About
    • Mandate & Strategy
    • Governance & COI Management
    • CITF Leadership
  • Research
    • About CITF-Funded Research
    • CITF-Funded Research Studies
      • Hybrid Immunity
      • Vaccine Surveillance
      • General Population & Other
      • Geographic, priority population, Indigenous & 2SLBGTQ+
      • Long-term Care & Seniors
      • Pediatric Studies
      • Healthcare Workers and Occupational Group Studies
      • Higher Risk Due to Health Conditions
      • Long COVID and Variants of Concern
      • Immune Science & Optimization of Immunological Testing Studies
      • Studies in the CITF Databank
    • CITF Research Results
    • SeroTracker
    • Published Research Papers
    • Tools & Information for Researchers
  • CITF Databank
  • Seroprevalence in Canada
  • Events
  • Media
    • Media Releases and CITF Announcements
    • News Coverage
  • Resources
    • CITF Monthly Review
    • Newsletter Back Issues
    • CITF & International Research Synthesis
    • Publications from our Experts
    • FAQs
  • Contact Us
  • FR
  • About
    • Mandate & Strategy
    • Governance & COI Management
    • CITF Leadership
  • Research
    • About CITF-Funded Research
    • CITF-Funded Research Studies
      • Hybrid Immunity
      • Vaccine Surveillance
      • General Population & Other
      • Geographic, priority population, Indigenous & 2SLBGTQ+
      • Long-term Care & Seniors
      • Pediatric Studies
      • Healthcare Workers and Occupational Group Studies
      • Higher Risk Due to Health Conditions
      • Long COVID and Variants of Concern
      • Immune Science & Optimization of Immunological Testing Studies
      • Studies in the CITF Databank
    • CITF Research Results
    • SeroTracker
    • Published Research Papers
    • Tools & Information for Researchers
  • CITF Databank
  • Seroprevalence in Canada
  • Events
  • Media
    • Media Releases and CITF Announcements
    • News Coverage
  • Resources
    • CITF Monthly Review
    • Newsletter Back Issues
    • CITF & International Research Synthesis
    • Publications from our Experts
    • FAQs
  • Contact Us
  • FR
  • About
    • Mandate & Strategy
    • Governance & COI Management
    • CITF Leadership
  • Research
    • About CITF-Funded Research
    • CITF-Funded Research Studies
      • Hybrid Immunity
      • Vaccine Surveillance
      • General Population & Other
      • Geographic, priority population, Indigenous & 2SLBGTQ+
      • Long-term Care & Seniors
      • Pediatric Studies
      • Healthcare Workers and Occupational Group Studies
      • Higher Risk Due to Health Conditions
      • Long COVID and Variants of Concern
      • Immune Science & Optimization of Immunological Testing Studies
      • Studies in the CITF Databank
    • CITF Research Results
    • SeroTracker
    • Published Research Papers
    • Tools & Information for Researchers
  • CITF Databank
  • Seroprevalence in Canada
  • Events
  • Media
    • Media Releases and CITF Announcements
    • News Coverage
  • Resources
    • CITF Monthly Review
    • Newsletter Back Issues
    • CITF & International Research Synthesis
    • Publications from our Experts
    • FAQs
  • Contact Us
  • FR

News Coverage

News CoverageSimon Labonne2021-02-26T13:24:42-05:00

COVID-19 Immunity Task Force

The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada.

The COVID-19 Immunity Task Force Secretariat is housed at the McGill University School of Population and Global Health.

info@covid19immunitytaskforce.ca
media@covid19immunitytaskforce.ca

Intranet Login

Tweets by @COVIDimmunityTF

The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada.

Copyright 2021 | COVID-19 Immunity Task Force | All rights reserved
TwitterFacebookLinkedIn
Page load link
Go to Top